Viatris company profile

VTRS · NASDAQ · USD

Compare Viatris
$20.45Change from previous close: −1.40%Absolute change: −$0.29

Close · November 17, 2026

Company profile

Viatris has 30,000 employees and is headquartered in Canonsburg, United States.

Viatris Inc. is based in Canonsburg, Pennsylvania, and has existed since its founding in 1961. Together with its subsidiaries, the healthcare company develops and sells prescription brand drugs, generic drugs, complex generics and biosimilars in areas such as cardiovascular, CNS and anesthesia, diabetes and metabolism, oncology, and respiratory and allergy. Its brands include Lipitor, Viagra, Lyrica and EpiPen Auto-Injector, supplied as oral solid doses, injectables and complex dosage forms to pharmacies, wholesalers, payers, insurers, governments and institutions. Operations span North America, Europe, China, Japan, Australia, Africa, Latin America and the Middle East, organized into four segments: Developed Markets, Greater China, JANZ and Emerging Markets.

In the fiscal year ended December 2025, Viatris reported revenue of USD 14.3 billion, down 3.0% from the previous year, and a net loss of USD 3.5 billion. The United States accounted for 12.7% of revenue and China for 8.8%. The company had 30,000 employees.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Robert J. Coury Global Center, 15317, Canonsburg
Employees
30,000
Chief executive
Scott Smith
Founded
1961
Fiscal year
January - December
Listing
VTRS · NASDAQ
Indices
S&P 500
Currency
USD
ISIN
US92556V1061

Viatris and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ViatrisVTRSUnited States$23.58B30,000——
United TherapeuticsUTHRUnited States$25.04B1,40039.4%22.2
Neurocrine BiosciencesNBIXUnited States$16.73B2,50026.6%24.5
ZoetisZTSUnited States$33.92B14,50037.9%14.1
Teva Pharmaceutical IndustriesTEVAUnited States$49.67B31,17319.8%99.0
Hims & Hers HealthHIMSUnited States$4.13B2,442-6.4%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Viatris with its competitors